Immunogenicity
PROLIFERATION
The T-cell proliferation test was performed only in the GV1001 group, and the number and percentage of patients in FAS population with positive T-cell proliferation test was 19 patients (25.33%) at week 1, 14 patients (18.67%) at week 10, 14 (18.67%) patients at week 14, and 12 patients (16·00%) at week 18. A total of 35 patients with positive result in T-cell proliferation tests reported median OS as 12.3 months (95% CI, 7.1–17.5), which was not significantly increased than 40 patients with negative T-cell proliferation tests (10.6 months [95% CI, 5.7–15.5], In addition, CD8